Alvotech (ALVO) Long-Term Debt Issuances (2022 - 2026)
Alvotech (ALVO) posted Long-Term Debt Issuances of $13.5 million for Q1 2026, down 94.22% on a QoQ basis from $233.5 million in Q4 2025.
Alvotech (ALVO) Long-Term Debt Issuances (2022 - 2026) Analysis & Trends
Alvotech's Long-Term Debt Issuances history runs 5 years deep, the most recent figure standing at $13.5 million for Q1 2026.
- Quarterly Long-Term Debt Issuances changed N/A year-over-year to $13.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (changed N/A YoY) and the FY2025 annual result came in at $233.5 million, down 73.95% from the prior year.
- Long-Term Debt Issuances was $13.5 million for Q1 2026 at Alvotech, down from $233.5 million in the prior quarter.
- Across five years, Long-Term Debt Issuances topped out at $895.4 million in Q4 2024 and bottomed at -$897.5 million in Q2 2024.
- A 5-year average of $27.7 million and a median of $25.0 million in 2022 frame the typical range for Long-Term Debt Issuances.
- Peak annual rise in Long-Term Debt Issuances reached 2539.4% in 2024, while the deepest fall reached 2808.21% in 2024.
- Alvotech's Long-Term Debt Issuances stood at -$14.2 million in 2022, then surged by 338.66% to $33.9 million in 2023, then soared by 2539.4% to $895.4 million in 2024, then slumped by 73.92% to $233.5 million in 2025, then tumbled by 94.22% to $13.5 million in 2026.
- Business Quant data shows ALVO's Long-Term Debt Issuances at $13.5 million in Q1 2026, $233.5 million in Q4 2025, and -$11.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.64 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Alvotech | 935.87 Mn | 935.87 Mn | 5.09 Mn | 13.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.50 Mn |
| Mar 31, 2026 | 13.50 Mn |
| Dec 31, 2025 | 233.47 Mn |
| Dec 31, 2025 | 233.47 Mn |
| Sep 30, 2025 | -11.25 Mn |
| Sep 30, 2025 | -11.25 Mn |
| Dec 31, 2024 | 895.36 Mn |
| Dec 31, 2024 | 895.36 Mn |
| Sep 30, 2024 | -66.60 Mn |
| Sep 30, 2024 | -66.60 Mn |
| Jun 30, 2024 | -897.50 Mn |
| Jun 30, 2024 | -897.50 Mn |
| Dec 31, 2023 | 33.92 Mn |
| Dec 31, 2023 | 33.92 Mn |
| Jun 30, 2023 | 33.14 Mn |
| Jun 30, 2023 | 33.14 Mn |
| Mar 31, 2023 | 60.42 Mn |
| Mar 31, 2023 | 60.42 Mn |
| Jun 30, 2022 | -14.21 Mn |
| Jun 30, 2022 | -14.21 Mn |